Scientific Articles
Vol. 15 No. 1 (2011)
https://doi.org/10.4081/microscopie.2011.4978

In vitro ageing of myotubes derived from myoblasts of patients affected by myotonic dystrophy type 2: ultrastructural evidence

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 15 January 2015
Published: 31 March 2011
560
Views
1067
Downloads
myotonic dystrophy type 2-DM2, myoblast, myotube, cell senescence, fluorescence microscopy, electron microscopy.

Authors

M. Giagnacovo
marzia.giagnacovo@unipv.it
Dipartimento di Biologia Animale, Laboratorio di Biologia cellulare e Neurobiologia, Università di Pavia, Pavia, Italy.
M. Costanzo
Dipartimento di Biologia Animale, Laboratorio di Biologia cellulare e Neurobiologia, Università di Pavia, Pavia, Italy.
R. Cardani
Dipartimento di Biologia molecolare e Biotecnologie, Università degli Studi di Milano, Milano; Centro per lo studio delle Malattie Neuromuscolari-CMN, Università degli Studi di Milano, Milano, Italy.
P. Veneroni
Dipartimento di Biologia Animale, Laboratorio di Biologia cellulare e Neurobiologia, Università di Pavia, Pavia, Italy.
C. Pellicciari
Dipartimento di Biologia Animale, Laboratorio di Biologia cellulare e Neurobiologia, Università di Pavia, Pavia, Italy.
G. Meola
Dipartimento di Neurologia, IRCCS Policlinico San Donato, Università degli Studi di Milano, Milano, Italy.
Myotonic dystrophy type 2 (DM2) is a dominantly inherited autosomal disease with multi-systemic clinical features and is caused by expansion of a CCTG tetranucleotide repeat in the first intron of the zinc finger protein 9 (ZNF9) gene in 3q21. The expanded- CCUG-containing transcripts are retained in cell nuclear domains (called foci) which specifically sequester some splicing factors, thus causing a general alteration of the pre-mRNA post-transcriptional pathway that is likely responsible for the multifactorial phenotype of DM2 patients. However, at the skeletal muscle level, there is still no mechanistic explanation for the muscle weakness and atrophy of DM2 patients. It has been noted that in DM2 patients skeletal muscle regeneration is decreased, suggesting an impaired responsiveness of satellite cells to regeneration stimuli as much as it occurs in ageing muscles. In order to investigate the differentiation potential of senesceing DM2 myoblasts and the development of the derived myotubes, we developed a model system of cell ageing in vitro: by this approach, the structural features of myotubes derived from DM2 myoblasts grown in culture for increasing times have been investigated by fluorescence and transmission electron microscopy. Apparent alterations of several cytoplasmic features have been observed in the myotubes derived from myoblasts at higher passages. This strongly argues in favour of the involvement of satellite cell senescence in the reduced regenerative potential of dystrophic muscles.

Downloads

Download data is not yet available.

How to Cite



In vitro ageing of myotubes derived from myoblasts of patients affected by myotonic dystrophy type 2: ultrastructural evidence. (2011). Microscopie, 15(1), 60-67. https://doi.org/10.4081/microscopie.2011.4978

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

  1. the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.